A clinical trial investigating the experimental weight loss drug retatrutide suggests it may not only prevent the progression of liver disease but potentially reverse it. According to Dr. Arun Sanyal,
Continue readingExperimental Weight Loss Drug Shows Promise in Treating Liver Disease
Mounjaro (tirzepatide) and Ozempic (semaglutide) – What’s the difference? …
Continue readingMounjaro (tirzepatide) and Ozempic (semaglutide) – What’s the difference?
Semaglutide, a GLP-1 receptor agonist found in medications such as Ozempic, Rybelsus, and Wegovy, has been shown to provide significant benefits for long-term weight loss and cardiovascular health. Weight Loss
Continue readingSemaglutide has BOTH Weight Loss & Cardiovascular Health benefits
The SURMOUNT-4 phase 3 clinical trial, led by researchers at Weill Cornell Medicine and NewYork-Presbyterian, investigated the effectiveness of anti-obesity drugs, particularly tirzepatide, in maintaining weight loss over the long